← Back to Markets

GLMD

Galmed Pharmaceuticals Ltd · NASDAQ NMS - GLOBAL MARKET · Biotechnology

$0.58+$0.06 (+10.56%)

Prices delayed up to 5 minutes

AC Intelligence

AC Intelligence

AC Intelligence for GLMD is being prepared.

Key Stats

Key Stats

Open

$0.53

Day High

$0.58

Day Low

$0.51

Prev Close

$0.52

Volume

0

Avg Volume

32.9K

Day Change

+$0.06

Change %

+10.56%

Fundamentals

Fundamentals

P/B

0.29

EPS (TTM)

$-3.60

Market Cap

$3M

52-Wk Range

$0.41 — $2.68

Who Owns This Stock

Who Owns GLMD

Other81.4%12 holders
Tactical / Macro17.2%1 holder
Dealer / Bank1.4%4 holders

Based on Q4 2025 13F filings + AC behavioral model

17 institutional holders

Top Holders

1.TWO SIGMA INVESTMENTS, LP
$84.2B
2.Citadel Advisors
-24.4%$28.7B
3.TWO SIGMA ADVISERS, LP
$23.6B
4.TWO SIGMA SECURITIES, LLC
$10.2B
5.JANE STREET GROUP, LLC
$9.1B
6.XTX Topco Ltd
$8.3B
7.UBS Group AG
+88.6%$1.4B
$675M
9.Morgan Stanley IM
$150M
10.Morgan Stanley IM
$74M
11.SBI Securities Co., Ltd.
0.0%$12M
13.Wells Fargo & Company
0.0%$7M
14.JANE STREET GROUP, LLC
$4M
15.OSAIC HOLDINGS, INC.
$3M
16.UBS Group AG
-99.7%$2M
17.Allworth Financial LP
0.0%$2M
18.ELEVATION WEALTH PARTNERS, LLC
0.0%$1M
19.Dogwood Wealth Management LLC
0.0%$1M
20.TSFG, LLC
0.0%$0K

Institutional Pressure

Market Regime:Strong Risk-Off (-0.62)
SELLINGBUYING
Moderate Selling Pressure
Other(81.4%)
Tactical / Macro(17.2%)
Reducing rapidly
Dealer / Bank(1.4%)
Facilitating

Updated daily · Based on Q4 2025 filings + AC behavioral model

Sentiment Signals

Sentiment Signals

Insider ActivityNo insider transactions in last 90 daysSEC Form 4
Analyst Consensus0 buy, 3 hold, 3 sellFinnhub
↑↑Inst. Flows12 increased/new, 2 decreased/exited (13F)AC 13F Analysis

Sources: SEC Form 4, Finnhub, AC 13F Analysis

On AcidCapitalist

On AcidCapitalist

No recent mentions of GLMD on AcidCapitalist.

Data provided by Finnhub. Prices delayed up to 5 minutes.